IEH Corp director sells 5,000 shares at ~$33
A company director amended prior disclosures and reported selling 5,000 IEH Corp common shares in early September 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
IEH Corp (IEHC) reported an amended insider trading disclosure for director Michael E. Rosenfeld. The amendment corrects dates and prices from a prior Form 4 filed on August 20, 2026 and adds further sales of common stock. On September 3–4, 2026, Rosenfeld reported selling a total of 5,000 shares of IEH common stock in open market or private transactions at prices between $32.51 and $32.95 per share. No Rule 10b5-1 trading plan is indicated, and the filing does not state Rosenfeld’s holdings after these transactions.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock, par value $0.01 per share | 3,800 | $32.5642 | $124K |
| Sale | Common Stock, par value $0.01 per share | 1,000 | $32.95 | $33K |
| Sale | Common Stock, par value $0.01 per share | 100 | $32.77 | $3K |
| Sale | Common Stock, par value $0.01 per share | 100 | $32.51 | $3K |
Key Figures
Key Terms
Form 4/A regulatory
non-derivative financial
open market or private transaction financial
Rule 10b5-1 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the amended Form 4/A for IEHC disclose about insider trades?
Were the IEHC insider sales made under a Rule 10b5-1 trading plan?
Why was this IEHC Form 4/A filed as an amendment?
AI-generated analysis. How Rhea-AI works. Not financial advice.